Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.

Pakdaman H, Harandi A A, Gharagozli K, Abbasi M, Tabassi A, Ashrafi F, Ghaffarpor M, Sharifi S, Kasmae H D, Assarzadegan F, et al.

Int J Neurosci. 2016 Jul 19:1-7. PMID: 27279451. Abstract